Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.

---

Autoria(s): Moreau P.; Garban F.; Attal M.; Michallet M.; Marit G.; Hulin C.; Benboubker L.; Doyen C.; Mohty M.; Yakoub-Agha I.; Leyvraz S.; Casassus P.; Avet-Loiseau H.; Garderet L.; Mathiot C.; Harousseau J.L.

Data(s)	2008
Identificador	http://serval.unil.ch/?id=serval:BIB_7F5FDC892B37 isbn:1528-0020 pmid:18948589 doi:10.1182/blood-2008-07-168823 isiid:000260301800052
Idioma(s)	en
Fonte	Blood, vol. 112, no. 9, pp. 3914-3915
Palavras-Chave	#Disease-Free Survival; Follow-Up Studies; Humans; Multiple Myeloma; Risk Factors; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous
Tipo	info:eu-repo/semantics/article article